Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Journal of Leukocyte Biology|December 19, 2002
Ethanol-induced inhibition of cytokine release and protein degranulation in human neutrophilsJulien Taïeb, Charlotte Delarche, Fréderic Ethuin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2006
Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: a multicenter phase II study with dose adjustment according to baseline serum bilirubin levelValérie Boige, Julien Taïeb, Mohamed Hebbar, et al.
Cancer|March 3, 2007
Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II studySamy Louafi, Valérie Boige, Michel Ducreux, et al.
Cancer|March 23, 2011
Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO studyAziz Zaanan, Mélanie Gauthier, David Malka, et al.
Gastroenterologie Clinique Et Biologique|August 24, 2002
[5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer]Julien Taïeb, Thierry Lecomte, Joël Ezenfis, et al.
Journal of Hepatology|February 28, 2002
Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitisJulien Taïeb, Charlotte Delarche, Valérie Paradis, et al.
Journal of Hepatology|September 20, 2012
Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO studyAziz Zaanan, Nicolas Williet, Mohamed Hebbar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II studyJulien Taïeb, Pascal Artru, François Paye, et al.
Cancer|December 12, 2003
Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedulesJulien Taïeb, Luminita Bonyhay, Lamia Golli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 3, 2020
"Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial"Julien Taïeb, Léonor Benhaim, Pierre Laurent Puig, et al.
Pageof 5